Clearmind enrolls first AUD patients in CMND-100 trial

Go back to Clearmind enrolls first AUD patients in CMND-100 trial
(NASDAQ: CMND) Delayed: 6.00 +0.06 (1.01%)
Previous Close $5.94    52 Week High $ 
Open $6.01    52 Week Low $ 
Day High $6.10    P/E N/A 
Day Low $6.00    EPS $ 
Volume 5,300